Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy

American Journal of Gastroenterology

Volumn 95, Issue 2, 2000, Pages 457-462

  Mönkemüller, Klaus E ^a   Call, Stephanie A ^a   Lazenby, Audrey J ^b   Wilcox, C Mel ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALABAMA; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INTESTINAL MUCOSA; MALE; PREVALENCE; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 11244332159     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00827-8     Document Type: Article

References (15)

1. Wilcox C.M., Straub R.F., Schwartz D.A. Cytomegalovirus esophagitis in AIDS A prospective study of clinical response to ganciclovir therapy, relapse rate, and long-term outcome . Am J Med. 98:1995;169-176.
2. Mönkemüller K.E., Wilcox C.M. Diagnosis and treatment of colonic disease in AIDS. Gastrointest Endosc Clin North Am. 8:1998;889-911.
3. Coffin J.M. HIV population dynamics in vivo Implications for genetic variation, pathogenesis and therapy . Science. 267:1995;483-489.
4. Hammer S.M., Katzenstein D.A., Hughes M.D., et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic milimeter. N Engl J Med. 335:1996;1081-1090.
5. Bartlett J.A., Benoit S.L., Johnson V.A., et al. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV-infection A randomized, double blind, placebo controlled trial . Ann Intern Med. 125:1996;161-172.
6. Hammer S.M., Squires K.E., Hughes M.D., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic milimeter or less. N Engl J Med. 337:1997;725-733.
7. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 338:1998;853-860.
8. O'Brien W.A., Hartigan P.M., Martin D., et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med. 334:1996;426-431.
9. Anonymous. Update. Trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:165-73.
10. Torres R.A., Barr M. Impact of combination therapy for HIV-infection on inpatient census. N Engl J Med. 336:1997;1531-1532.
11. Hogg R.S., O'Shaughnessy M.V., Gataric N., et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet. 349:1997;1294.
12. Blum L., Pellet C., Agbalika F., et al. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS. 11:1997;1653-1655.
13. Carr A., Marriott D., Field A., et al. Treatment of HIV-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet. 1998;351-354.
14. Beltrami J.F., Vermund S.H., Fawal H.J., et al. HIV/AIDS in nonurban Alabama Risk activities and access to services among HIV-infected persons . South Med J. 92:1999;83.
15. Lucas G.M., Chaisson R.E., Moore R.D. Highly active antiretroviral therapy in a large urban clinic Risk factors for virologic failure and adverse drug reactions . Ann Intern Med. 131:1999;81-87.